Epidemiology

You have full text access to this OnlineOpen article

Personal sun exposure and risk of non Hodgkin lymphoma: A pooled analysis from the Interlymph Consortium

  1. Anne Kricker1,*,
  2. Bruce K. Armstrong1,
  3. Ann Maree Hughes2,
  4. Chris Goumas1,
  5. Karin Ekström Smedby3,
  6. Tongzhang Zheng4,
  7. John J. Spinelli5,
  8. Sylvia De Sanjosé6,
  9. Patricia Hartge7,
  10. Mads Melbye8,
  11. Eleanor V. Willett2,
  12. Nikolaus Becker9,
  13. Brian C.H. Chiu10,
  14. James R. Cerhan11,
  15. Marc Maynadié12,
  16. Anthony Staines13,
  17. Pierluigi Cocco14,
  18. Paolo Boffeta15

Article first published online: 20 AUG 2007

DOI: 10.1002/ijc.23003

Issue

International Journal of Cancer

International Journal of Cancer

Volume 122, Issue 1, pages 144–154, 1 January 2008

Additional Information

How to Cite

Kricker, A., Armstrong, B. K., Hughes, A. M., Goumas, C., Smedby, K. E., Zheng, T., Spinelli, J. J., De Sanjosé, S., Hartge, P., Melbye, M., Willett, E. V., Becker, N., Chiu, B. C.H., Cerhan, J. R., Maynadié, M., Staines, A., Cocco, P. and Boffeta, P. (2008), Personal sun exposure and risk of non Hodgkin lymphoma: A pooled analysis from the Interlymph Consortium. Int. J. Cancer, 122: 144–154. doi: 10.1002/ijc.23003

Author Information

  1. 1

    School of Public Health, University of Sydney, Sydney, New South Wales, Australia

  2. 2

    Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom

  3. 3

    Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden

  4. 4

    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT

  5. 5

    Cancer Control Research Program, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  6. 6

    Epidemiology and Cancer Registry Unit, Catalan Institute of Oncology, Barcelona, Spain

  7. 7

    Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD

  8. 8

    Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark

  9. 9

    Division of Clinical Epidemiology, German Cancer Research Centre, Heidelberg, Germany

  10. 10

    Department of Preventive Medicine, Northwestern University Medical School, Chicago, IL

  11. 11

    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN

  12. 12

    Registre des Hemopathies Malignes de Cote d'Or, Faculte de Medecine de Dijon, Dijon, France

  13. 13

    School of Public Health, University College Dublin, Ireland

  14. 14

    Department of Public Health, Occupational Health Section, University of Cagliari, Italy

  15. 15

    Unit of Environmental Cancer Epidemiology, International Agency for Research on Cancer, Lyon, France

*School of Public Health, Edward Ford Building A27, University of Sydney NSW 2006 Australia

Publication History

  1. Issue published online: 26 OCT 2007
  2. Article first published online: 20 AUG 2007
  3. Manuscript Accepted: 11 JUN 2007
  4. Manuscript Received: 7 APR 2007

Funded by

  • NCI. Grant Numbers: CA62006, PC65064, PC67008, PC67009, PC67010, PC71105
  • American Institute for Cancer Research. Grant Numbers: 99B083, CA92153
  • National Health and Medical Research Council, Australia. Grant Number: 990920
  • European Commission 5th Framework Program, Quality of Life. Grant Number: QLK4-CT-2000-00422
  • Spanish Ministry of Health. Grant Numbers: 04-0091, CIBER 06/0073
  • La Fondation de France. Grant Number: 1999-. 1999 008471
  • German Federal Office for Radiation Protection. Grant Numbers: StSch4261, StSch4420
  • NIH. Grant Number: 5RO1 CA69269-02
  • Swedish Cancer Society. Grant Number: 02 661
  • The Cancer Council NSW, University of Sydney Medical Foundation Program Grant, National Cancer Institute of Canada, the Chan Sisters Foundation, the Canadian Institutes for Health Research, the Leukaemia Research Fund, Compagnia di San Paolo di Torino, Programma Oncologia 2001, the Health Research Board (Ireland), Plan Denmark, The Danish National Research Foundation (SCALE)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (232K)

References

  • 1
    Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. BMJ 1995; 310: 1491–5.
  • 2
    Levi F, Randimbison L, Te VC, La VC. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996; 74: 1847–50.
  • 3
    Hemminki K, Jiang Y, Steineck G. Skin cancer and non-Hodgkin's lymphoma as second malignancies—markers of impaired immune function? Eur J Cancer 2003; 39: 223–9.
  • 4
    Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935–1988. Cancer 1992; 70: 840–9.
    Direct Link:
  • 5
    Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich AE, Fritschi L, Milliken S, Kaldor J, Benke G, Kricker A. Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int J Cancer 2004; 112: 865–71.
    Direct Link:
  • 6
    Smedby KE, Hjalgrim H, Melbye M, Torrang A, Rostgaard K, Munksgaard L, Adami J, Hansen M, Porwit-MacDonald A, Jensen BA, Roos G, Pedersen BB, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005; 97: 199–209.
  • 7
    Hartge P, Lim U, Freedman DM, Colt JS, Cerhan JR, Cozen W, Severson RK, Davis S. Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 2006; 17: 1045–52.
  • 8
    Weihkopf T, Becker N, Nieters A, Mester B, Deeg E, Elsner G, Blettner M, Seidler A. Sun exposure and malignant lymphoma: a population-based case-control study in Germany. Int J Cancer 2007; 120: 2445–51.
    Direct Link:
  • 9
    Zhang Y, Holford TR, Leaderer B, Boyle P, Zhu Y, Wang R, Zou K, Zhang B, Wise JP,Sr, Qin Q, Kilfoy B, Han J, et al. Ultraviolet radiation exposure and risk of non-Hodgkin's lymphoma. Am J Epidemiol 2007; 165: 1255–64.
  • 10
    deSanjose S, Benavente Y, Nieters A, Foretova L, Maynadie M, Cocco PL, Staines A, Vornanen M, Boffetta P, Becker N, Alvaro T, Brennan P. Association between personal use of hair dyes and lymphoid neoplasms in Europe. Am J Epidemiol 2006; 164: 47–55.
  • 11
    Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich A, Fritschi L, Milliken S, Kaldor J, Benke G, Kricker A. Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma. Int J Cancer 2004; 110: 429–34.
    Direct Link:
  • 12
    Chiu BC, Kolar C, Gapstur SM, Lawson T, Anderson JR, Weisenburger DD. Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study. Br J Haematol 2005; 128: 610–15.
    Direct Link:
  • 13
    Willett EV, Smith AG, Dovey GJ, Morgan GJ, Parker J, Roman E. Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma. Cancer Causes Control 2004; 15: 771–80.
  • 14
    Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumours of the haematopoietic and lymphoid tissues. In: KleihuesP,SobinLH, eds. World Health Organisation Classification of Tumours. Lyon: IARC Press, 2001.
  • 15
    Morton LM, Zheng T, Holford TR, Holly EA, Chiu BC, Costantini AS, Stagnaro E, Willett EV, Dal Maso L, Serraino D, Chang ET, Cozen W, et al. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 2005; 6: 469–76.
  • 16
    Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke VA, Jack A, Cozen W, Maynadie M, Spinelli JJ, Constantini AS, Rudiger T, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007; 110: 695–708.
  • 17
    English DR, Armstrong BK, Kricker A, Winter MG, Heenan PJ, Randell PL. Case-control study of sun exposure and squamous cell carcinoma of the skin. Int J Cancer 1998; 77: 347–53.
    Direct Link:
  • 18
    Kricker A, Armstrong BK, English DR, Heenan PJ. A dose-response curve for sun exposure and basal cell carcinoma. Int J Cancer 1995; 60: 482–8.
    Direct Link:
  • 19
    Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, Armstrong BK. Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer 2002; 101: 175–82.
    Direct Link:
  • 20
    English DR, Armstrong BK, Kricker A. Reproducibility of reported measurements of sun exposure in a case-control study. Cancer Epidemiol Biomarkers Prev 1998; 7: 857–63.
  • 21
    Kricker A, Vajdic CM, Armstrong BK. Reliability and validity of a telephone questionnaire for estimating lifetime personal sun exposure in epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2005; 14: 2427–32.
  • 22
    Karagas MR, Zens MS, Nelson HH, Mabuchi K, Perry AE, Stukel TA, Mott LA, Andrew AS, Applebaum KM, Linet M. Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damage. Am J Epidemiol 2007; 165: 719–26.
  • 23
    Stukel TA, Demidenko E, Dykes J, Karagas MR. Two-stage methods for the analysis of pooled data. Stat Med 2001; 20: 2115–30.
    Direct Link:
  • 24
    Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9: 1–30.
  • 25
    The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997; 89: 3909–18.
  • 26
    Clarke CA, Glaser SL, Dorfman RF, Bracci PM, Eberle E, Holly EA. Expert review of non-Hodgkin's lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classifications. Cancer Epidemiol Biomarkers Prev 2004; 13: 138–43.
  • 27
    Newton R. Non-Hodgkin's lymphoma and skin cancer. American data refute ultraviolet hypothesis. BMJ 1995; 311: 750–1.
  • 28
    Hartge P, Devesa SS, Grauman D, Fears TR, Fraumeni JF. Non-Hodgkin's lymphoma and sunlight. J Natl Cancer Inst 1996; 88: 298–300.
  • 29
    McMichael AJ, Giles GG. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer 1996; 73: 945–50.
  • 30
    Bentham G. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales. BMJ 1996; 312: 1128–31.
  • 31
    Hardell L, Eriksson M, Degerman A. Exposure to phenoxyacetic acids, chlorophenols, or organic solvents in relation to histopathology, stage, and anatomical localization of non-Hodgkin's lymphoma. Cancer Res 1994; 54: 2386–9.
  • 32
    Freedman DM, Zahm SH, Dosemeci M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study. BMJ 1997; 314: 1451–5.
  • 33
    vanWijngaarden E, Savitz DA. Occupational sunlight exposure and mortality from non-Hodgkin lymphoma among electric utility workers. J Occup Environ Med 2001; 43: 548–53.
  • 34
    Lens MB, Newton-Bishop JA. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review. Ann Oncol 2005; 16: 460–5.
  • 35
    Brennan P, Scelo G, Hemminki K, Mellemkjaer L, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, Seow A, et al. Second primary cancers among 109,000 cases of non-Hodgkin's lymphoma. Br J Cancer 2005; 93: 159–66.
  • 36
    Iscovich J, Paltiel O, Azizi E, Kuten A, Gat A, Lifzchitz-Mercer B, Zlotogorski A, Polliack A. Cutaneous lymphoma in Israel, 1985–1993: a population-based incidence study. Br J Cancer 1998; 77: 170–3.
  • 37
    McGregor JM, Crook T, Fraser-Andrews EA, Rozycka M, Crossland S, Brooks L, Whittaker SJ. Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. J Invest Dermatol 1999; 112: 317–21.
  • 38
    Holick MF. McCollum Award Lecture, 1994: vitamin D—new horizons for the 21st century. Am J Clin Nutr 1994; 60: 619–30.
  • 39
    Hickish T, Cunningham D, Colston K, Millar BC, Sandle J, Mackay AG, Soukop M, Sloane J. The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer 1993; 68: 668–72.
  • 40
    Raina V, Cunningham D, Gilchrist N, Soukop M. Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer 1991; 63: 463–5.
  • 41
    Polesel J, Talamini R, Montella M, Parpinel M, Dal ML, Crispo A, Crovatto M, Spina M, La VC, Franceschi S. Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study. Ann Oncol 2006; 17: 713–18.
  • 42
    Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006; 98: 451–9.
View Full Article (HTML) Get PDF (232K)